2 withdrawn. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Withdrawn 2 |
Follow Dilatation, Pathologic: new trials by email Literature Review of Dilatation, Pathologic trials Research Report on Dilatation, Pathologic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks Misoprostol, Mifepristone, Hygroscopic cervical dilators - Legally Induced Abortion Without Mention of Complication | Not applicable | Withdrawn | Stanford University | 2016-04-01 | 2019-09-19 | |
| Higher Irradiance in Keratoconus Ectasia UVA Light with irradiance exposure of 9 mW/cm2, Riboflavin 0.1% ophthalmic solution - Keratoconus, Ectasia | Not applicable | Withdrawn | Stephen Trokel | 2010-09-01 | 2023-02-09 |
Keratoconus (1)
Pathological Conditions, Anatomical (2) · Pathological Conditions, Signs and Symptoms (2) · Corneal Diseases (1) · Eye Diseases (1)
Mifepristone (1) · Misoprostol (1) · Ophthalmic Solutions (1) · Riboflavin (1)
Stanford University (1) · Stephen Trokel (1)
United States (2)